353 related articles for article (PubMed ID: 37834350)
1. How Nitric Oxide Hindered the Search for Hemoglobin-Based Oxygen Carriers as Human Blood Substitutes.
Samaja M; Malavalli A; Vandegriff KD
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834350
[TBL] [Abstract][Full Text] [Related]
2. HBOC vasoactivity: interplay between nitric oxide scavenging and capacity to generate bioactive nitric oxide species.
Cabrales P; Friedman JM
Antioxid Redox Signal; 2013 Jun; 18(17):2284-97. PubMed ID: 23249305
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the oxidative reactivity of recombinant fetal and adult human hemoglobin: implications for the design of hemoglobin-based oxygen carriers.
Simons M; Gretton S; Silkstone GGA; Rajagopal BS; Allen-Baume V; Syrett N; Shaik T; Leiva-Eriksson N; Ronda L; Mozzarelli A; Strader MB; Alayash AI; Reeder BJ; Cooper CE
Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29802155
[TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of SNO-PEG-hemoglobin as a candidate for oxygen transporting material.
Nakai K; Togashi H; Yasukohchi T; Sakuma I; Fujii S; Yoshioka M; Satoh H; Kitabatake A
Int J Artif Organs; 2001 May; 24(5):322-8. PubMed ID: 11420882
[TBL] [Abstract][Full Text] [Related]
5. Normalization of hemoglobin-based oxygen carrier-201 induced vasoconstriction: targeting nitric oxide and endothelin.
Taverne YJ; de Wijs-Meijler D; Te Lintel Hekkert M; Moon-Massat PF; Dubé GP; Duncker DJ; Merkus D
J Appl Physiol (1985); 2017 May; 122(5):1227-1237. PubMed ID: 28183818
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms for vasoconstriction and decreased blood flow following intravenous administration of cell-free native hemoglobin solutions.
Kim HW; Greenburg AG
Adv Exp Med Biol; 2005; 566():397-401. PubMed ID: 16594178
[TBL] [Abstract][Full Text] [Related]
7. Development of recombinant hemoglobin-based oxygen carriers.
Varnado CL; Mollan TL; Birukou I; Smith BJ; Henderson DP; Olson JS
Antioxid Redox Signal; 2013 Jun; 18(17):2314-28. PubMed ID: 23025383
[TBL] [Abstract][Full Text] [Related]
8. Blood Component Requirements and Erythrocyte Transfusion and Mortality Related to Hemoglobin Deficit in Phase III Trial of Hemoglobin-Based Oxygen Carrier: HBOC-201.
Jahr JS; Williams JP
Am J Ther; 2022 May-Jun 01; 29(3):e279-e286. PubMed ID: 35421008
[TBL] [Abstract][Full Text] [Related]
9. Mixed S-nitrosylated polymerized bovine hemoglobin species moderate hemodynamic effects in acutely hypoxic rats.
Irwin D; Buehler PW; Alayash AI; Jia Y; Bonventura J; Foreman B; White M; Jacobs R; Piteo B; TissotvanPatot MC; Hamilton KL; Gotshall RW
Am J Respir Cell Mol Biol; 2010 Feb; 42(2):200-9. PubMed ID: 19395680
[TBL] [Abstract][Full Text] [Related]
10. Biochemical aspects of the reaction of hemoglobin and NO: implications for Hb-based blood substitutes.
Patel RP
Free Radic Biol Med; 2000 May; 28(10):1518-25. PubMed ID: 10927176
[TBL] [Abstract][Full Text] [Related]
11. Current Challenges in the Development of Acellular Hemoglobin Oxygen Carriers by Protein Engineering.
Benitez Cardenas AS; Samuel PP; Olson JS
Shock; 2019 Oct; 52(1S Suppl 1):28-40. PubMed ID: 29112633
[TBL] [Abstract][Full Text] [Related]
12. Engineering tyrosine electron transfer pathways decreases oxidative toxicity in hemoglobin: implications for blood substitute design.
Silkstone GG; Silkstone RS; Wilson MT; Simons M; Bülow L; Kallberg K; Ratanasopa K; Ronda L; Mozzarelli A; Reeder BJ; Cooper CE
Biochem J; 2016 Oct; 473(19):3371-83. PubMed ID: 27470146
[TBL] [Abstract][Full Text] [Related]
13. Hemoglobin-based red blood cell substitutes and nitric oxide.
Yu B; Bloch KD; Zapol WM
Trends Cardiovasc Med; 2009 Apr; 19(3):103-7. PubMed ID: 19679268
[TBL] [Abstract][Full Text] [Related]
14. Endothelial dysfunction enhances vasoconstriction due to scavenging of nitric oxide by a hemoglobin-based oxygen carrier.
Yu B; Shahid M; Egorina EM; Sovershaev MA; Raher MJ; Lei C; Wu MX; Bloch KD; Zapol WM
Anesthesiology; 2010 Mar; 112(3):586-94. PubMed ID: 20179495
[TBL] [Abstract][Full Text] [Related]
15. Red cell substitutes from hemoglobin--do we start all over again?
Kluger R
Curr Opin Chem Biol; 2010 Aug; 14(4):538-43. PubMed ID: 20392662
[TBL] [Abstract][Full Text] [Related]
16. Redox concerns in the use of acellular hemoglobin-based therapeutic oxygen carriers: the role of plasma components.
Harrington JP; Gonzalez Y; Hirsch RE
Artif Cells Blood Substit Immobil Biotechnol; 2000 Nov; 28(6):477-92. PubMed ID: 11063090
[TBL] [Abstract][Full Text] [Related]
17. Haemoglobin-based erythrocyte transfusion substitutes.
Standl T
Expert Opin Biol Ther; 2001 Sep; 1(5):831-43. PubMed ID: 11728218
[TBL] [Abstract][Full Text] [Related]
18. Hemoglobin solutions and tissue oxygenation.
Muir WW; Wellman ML
J Vet Intern Med; 2003; 17(2):127-35. PubMed ID: 12683610
[TBL] [Abstract][Full Text] [Related]
19. Acellular invertebrate hemoglobins as model therapeutic oxygen carriers: unique redox potentials.
Harrington JP; Kobayashi S; Dorman SC; Zito SL; Hirsch RE
Artif Cells Blood Substit Immobil Biotechnol; 2007; 35(1):53-67. PubMed ID: 17364471
[TBL] [Abstract][Full Text] [Related]
20. Nitrite reductase activity of hemoglobin as a systemic nitric oxide generator mechanism to detoxify plasma hemoglobin produced during hemolysis.
Minneci PC; Deans KJ; Shiva S; Zhi H; Banks SM; Kern S; Natanson C; Solomon SB; Gladwin MT
Am J Physiol Heart Circ Physiol; 2008 Aug; 295(2):H743-54. PubMed ID: 18552166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
